Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SAP18 pseudogene 3 (SAP18P3) is a processed pseudogene corresponding to the SAP18 gene, a subunit of the histone deacetylase complex implicated in transcriptional repression, apoptosis, and mRNA splicing[1][2][3]. While pseudogenes can occasionally influence gene regulation, there is no evidence supporting any functional role, protein product, or therapeutic relevance for SAP18P3. It is *not considered a therapeutic target*. Its designation as a pseudogene also means it is non-coding, marking it as distinct from the parental SAP18 gene, which is functionally active in numerous cellular processes[4][5]. Alternative meanings: This entry refers specifically to the *pseudogene*, not the protein-coding SAP18 gene. Please clarify if the intention is to refer to SAP18 (Sin3A-associated protein, 18 kDa), the functional protein, which does have a well-documented biological and disease-associated role[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SAP18 pseudogene 3 (SAP18P3).